Guide: A Strategic Framework for Implementing Expanded Access Programs in the US

Comprehensive Guide to Expanded Access Program Success

Expanded Access, often referred to as Compassionate Use, is a pathway established by U.S. Food and Drug Administration (FDA) regulations. This program allows patients with immediately life-threatening diseases to access investigational therapies or medical devices that have not yet received full FDA approval.